Exclusive Upstream Licenses. If Sangamo obtains an Exclusive Upstream License, such exclusively licensed intellectual property rights shall be included in the Licensed Technology and sublicensed to Pfizer under the terms and conditions of this Agreement (which sublicense shall be subject and subordinate to the terms and conditions of the Upstream License), and the agreement pursuant to which Sangamo obtains Control of such intellectual property rights shall automatically become an Upstream License under this Agreement.
Appears in 4 contracts
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc), Research Collaboration and License Agreement (Sangamo Therapeutics, Inc), Research Collaboration and License Agreement (Sangamo Therapeutics, Inc)
